Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes.

Abstract excerpt

Leucine-rich repeat kinase 2 (LRRK2) is a key player in the pathogenesis of Parkinson's disease. Mutations in LRRK2 are associated with increased kinase activity that correlates with cytotoxicity, indicating that kinase inhibitors may comprise promising disease-modifying compounds. However, before embarking on such strategies, detailed knowledge of the cellular deficits mediated by pathogenic LRRK2 in the context...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
• Share to Models, Biological